ClinicalTrials.Veeva

Menu

The Effectiveness of Mini-fluid Challenge in Predicting Fluid Responsiveness During Video Assisted Thoracic Surgery

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Mini-fluid Challenge in Video-Assisted Thoracic Surgery

Treatments

Drug: Crystalloid Solutions

Study type

Interventional

Funder types

Other

Identifiers

NCT03731377
201807009RINC

Details and patient eligibility

About

Perioperative fluid management is crucial for patients' outcome. Muller et al developed a "Mini-fluid challenge method " to predict fluid responsiveness and the efficacy. The investigators design the study to investigate the effectiveness of mini-fluid challenge test in video assisted thoracic surgery.

Full description

Perioperative fluid management is crucial for patients' outcome. Series of studies have indicated that adequate fluid management optimizes the cardiac out put, improves tissue perfusion, thus decrease the risk of postoperative morbidity. Muller et al developed a "Mini-fluid challenge method " to predict fluid responsiveness and the efficacy. Fluid status and proper perfusion condition in patients undergo thoracic surgery are especially crucial for the vulnerability of lung toward fluid overload. To the best of our knowledge, the efficacy of the test was not discussed in the perioperative care in video assisted thoracic surgery. The investigators design the study to investigate the effectiveness of mini-fluid challenge test in video assisted thoracic surgery.

Enrollment

100 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients receiving scheduled video assisted thoracic surgery
  • BMI 18.5~30 kg.m-2

Exclusion criteria

  • age younger then 20 yrs or elder than 80 yrs
  • pregnant women
  • patients in intensive care units
  • patients with the underlying disease including respiratory failure(FEV1/FVC < 70 % and FEV1 < 50%), heart failure(NYHA score =III、IV), kidney failure(eGFR< 60 ml.min-1.1.73m-2), liver failure
  • patients with ongoing infection
  • patient allergic to voluven

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

100 participants in 2 patient groups

Intubated group
Experimental group
Description:
Patient in this group will receive general anesthesia with endotracheal tube intubation to perform one lung ventilation. Patient will be paralyzed and controlled ventilation will be implied.
Treatment:
Drug: Crystalloid Solutions
Non-intubated group
Experimental group
Description:
Patient in this group will receive general anesthesia with laryngeal mask insertion. Patients in this group will not be paralyzed and keep spontaneous breathing to maintain one lung ventilation.
Treatment:
Drug: Crystalloid Solutions

Trial contacts and locations

1

Loading...

Central trial contact

Tzu Jung Wei; National Taiwan University Hospital

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems